Nuclear accumulation of RAC1 promotes nuclear plasticity, causing a loss of cytoplasmic active RAC1 with a concomitant increase in RhoA that drives actomyosin-mediated changes in cell morphology, the two attributes contribute to intensifying the aggressiveness of tumor cells [19]. The gene discussed is RAC1; the disease is neoplasm.